Open-label randomized comparative study of cefepime vs. meropenem in adults with severe community-acquired pneumonia
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 May 2016
At a glance
- Drugs Cefepime (Primary) ; Meropenem (Primary) ; Azithromycin; Erythromycin
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- 02 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 04 Mar 2013 Planned End Date 30 Oct 2013 added as reported by University Hospital Medical Information Network - Japan.
- 13 Apr 2012 New trial record